News
ISRG
377.08
+2.21%
8.15
Buy Rating Affirmed for Intuitive Surgical Following Positive Surgeon Feedback on da Vinci 5 Advancements
TipRanks · 3h ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 3h ago
Intuitive Surgical’s Market Leadership Bolstered by dV5 System Advancements: A Strong Buy Recommendation
TipRanks · 3h ago
Intuitive Surgical Stock (NYSE:ISRG): 2024 Kicks Off on a High Note
TipRanks · 9h ago
Stocks with the least price swings, most attractive option-sale candidates - JPM
Seeking Alpha · 17h ago
(ISRG) - Analyzing Intuitive Surgical's Short Interest
Intuitive Surgical's short percent of float has fallen 3.96% since its last report. The company has 3.41 million shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company in the hope that the price will fall.
Benzinga · 20h ago
Baron Health Care Fund Q1 2024 Shareholder Letter
Baron Health Care Fund advanced 8.92% in the quarter ended March 31, 2024. The Fund's performance was in line with the Russell 3000 Health Care Index and the S&P 500 Index. Investments in health care equipment, pharmaceuticals, and life sciences added the most value in the period.
Seeking Alpha · 20h ago
Should You Pick Abbott Stock At $105 After An Upbeat Q1?
NASDAQ · 23h ago
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
TipRanks · 1d ago
Martin Zweig Detailed Fundamental Analysis - ISRG
NASDAQ · 1d ago
Weekly Report: what happened at ISRG last week (0415-0419)?
Weekly Report · 2d ago
Intuitive Surgical (ISRG) Gets a Buy from Barclays
TipRanks · 2d ago
Intuitive Surgical: Hold Rating Amidst DV5 Rollout Delays and Market Headwinds
TipRanks · 2d ago
Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Accolade (ACCD) and Intuitive Surgical (ISRG)
TipRanks · 2d ago
Intuitive Surgical Price Target Raised to $421.00/Share From $412.00 by BTIG
Dow Jones · 4d ago
Intuitive Surgical Is Maintained at Buy by BTIG
Dow Jones · 4d ago
BTIG Maintains Buy on Intuitive Surgical, Raises Price Target to $421
Benzinga · 4d ago
Intuitive Surgical Is Maintained at Overweight by Piper Sandler
Dow Jones · 4d ago
Intuitive Surgical Price Target Raised to $435.00/Share From $425.00 by Piper Sandler
Dow Jones · 4d ago
Piper Sandler Maintains Overweight on Intuitive Surgical, Raises Price Target to $435
Benzinga · 4d ago
More
Webull provides a variety of real-time ISRG stock news. You can receive the latest news about Intuitive Surgical Inc through multiple platforms. This information may help you make smarter investment decisions.
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.